Poster sessions

Suivant


June 16, 2016
10:45-11:45:  poster session 1 : pathophysiology of respiratory sensations
1. Respiratory event-related potentials in patients with spinal cord injury (A. Harver)(available online)
2. Investigating variability in breathlessness in severe COPD patients to personalise management (C. Chin)
3. Dyspnea in Pulmonary Hypertension (N. Burki)
4. The impact of prenatal exposure to maternal anxiety on the perception of dyspnea in adulthood (E. Mangelschots et al.)
5. Conditioned respiratory threat in the subdivisions of the human periaqueductal gray (O. Faul et al.)
6. Repetitive, intense hyperpnea does not change perception of bronchoconstriction despite reduced bronchial reactivity in asthmatics – a pilot study (A. Eichenberger et al.)
7.(also oral communication). Sensations associated with experimentally-evoked cough in healthy volunteers  (J. Smith et al. )
 (also oral communication). Salivary diurnal cortisol profiles in patients with advanced disease and chronic refractory breathlessness: a cross-sectional study (R. Ryan et al. )
 (also oral communication). Modulation of dyspnea perception during walking exercise using visual distraction strategies in patients with COPD: a pilot study (L. Laviolette et al.)(available online)
10 (also oral communication).  Breathing and bodily self-consciousness: evidence for reciprocal interferences between experimental dyspnea and visuo-respiratory induced full body illusion (E. Allard et al.)
11  (also oral communication).  The anticipation of dyspnea: neural, genetic and emotional aspects in health and COPD  (A. von Leupoldt et al.) 

17:00-18:00: poster session 2: from ICU to advanced cancer: epidemiology and treatment of dyspnea 
1. Restricting dyspnea in older people: last year of life (M. Johnson et al.)
2. Emergency department presentations: acute-on-chronic dyspnoea (M. Johnson et al.)
3. Absolute dynamic lung volume explains the gender difference in activity-related breathlessness: the population-based ECRHS III study (M. Ekström et al.)(available online)
4. Breathlessness during the last week of life in palliative care (M. Ekström et al.)(available online)
5 (also oral communication).  Dyspnea is an independent predictor of poor outcome in COPD patients surviving acute hypercapnic respiratory failure (D. Adler et al.)
 (also oral communication). Daily measure of quality and intensity of dyspnea throughout hospitalizations (J. Stevens et al.)

 (also oral communication).  Who Experiences Higher and Increasing Breathlessness In Advanced Cancer? (M. Ekström et al. )(available online)
8. Treatment of acute dyspnea with morphine to avert respiratory failure (R. Schwartzstein).
9. Twenty years of measuring the affective dimension of dyspnea: Cautions and considerations (V. Carrieri-Kohlmann et al.)
10. Regional blood flow responses to morphine-mediated relief of laboratory-induced dyspnea in healthy subjects (K. Evans et al. )
11. Immediate release oral morphine relieves breathlessness and improves exercise endurance in advanced COPD (S. Abdallah et al. )
12. A phase III, multi-site, randomised, double blind, placebo controlled parallel arm study of daily extended release (ER) morphine for chronic breathlessness (D. Currow et al.)
13.  Controlled-delivery of aerosol furosemide (40 mg) does not improve consistency of treatment effect on laboratory-induced dyspnea (C. Morelot-Panzini et al.)
14 (also oral communication). Controlled-delivery of high dose aerosol furosemide (80 mg) does not improve consistency of dyspnea relief (R. Banzett et al.)
15  (also oral communication). The impact of early palliative assessment on hospitalized patients with severe dyspnea on symptom severity and length of stay (M. Johnson et al.) 

June 17, 2016
09:00-11:45 (with a pause from 10:30 to 10:45): poster session 3: Evaluation of dyspnoea : feasibility and multidimensional assessment
1. Mild, moderate, and severe intensity cut-points for the respiratory distress observation scale: a receiver operating characteristics curve analysis (M. Campbell and T. Templin)(poster available online)
2. Differences in perceptual experiences of breathlessness and impairment between people with moderate-severe COPD in Australia and the United Kingdom (K. Johnston et al.)
3. The benefit of doubt: the role of subjective certainty in the perception of dyspnea and pain (O. Van Den Bergh)
4. The breath of life. patients' experiences of breathing during and after mechanical ventilation – a qualitatively-driven mixed method study (H.S. Haugdahl et al.)
5. A preliminary study shows ICU clinicians underestimate breathing discomfort in ventilated patients (A. Binks et al.)
6 (also oral communication). Comparison of the Dyspnea-12 and Multidimensional Dyspnea Profile in people with COPD (M. Williams et al.)
7.  (also oral communication). Dyspnoea-12 scores reported “these days” are greater than those reported “today” when completed at clinic attendance versus home in people with asthma, COPD and ILD- (K Johnston et al.)
8.  (also oral communication). Dyspnea upon admission in the intensive care unit (ICU): patients’ characteristics, verbal descriptors, and association with prognostic (R. Persichini et al.)
9.  (also oral communication). Routine Dyspnea Assessment: Feasibility and Acceptance of by Nurses (presented by K. Baker et al.)
10.  (also oral communication). Development of a dyspnoea challenge: reliability and comparison with the six minute walk test ( N. Morris et al.(available online)

-© Dyspnea2016inParis